NEW YORK – AbCellera Biologics said on Friday that it has filed a patent infringement lawsuit against Berkeley Lights in the United States District Court for the District of Delaware.
AbCellera claims that Berkeley Lights is infringing on eights of its patents — US Patent Nos. 10,107,812; 10,274,494; 10,466,241; 10,578,618; 10,697,962; 10,087,408; 10,421,936; and 10,704,018 — which cover AbCellera's proprietary platforms directed to the use of microfluidics for single-cell antibody discovery, cell clone culture and selection, and genomic sequencing using nanoliter-volume chambers.
AbCellera is asking the Court for a declaration that Berkeley Lights directly and indirectly infringed the patents. The company is seeking damages, as well as a permanent injunction preventing Berkeley Lights from using AbCellera's patented inventions for internal discovery programs and from selling any instrument or device that practices AbCellera's patented inventions in the US.
Berkeley Lights did not immediately respond to request for comment.